ArticleSeminars in immunology2024
The origins, manifestations, and potential treatments of allergic disorders.
Donata Vercelli, Stephen J Galli
Abstract readEditorial
In one paragraphArticle in Seminars in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors.
Donata VercelliDepartment of Cellular and Molecular Medicine, Asthma & Airway Disease Research Center, The BIO5 Institute, and the Arizona Center for the Biology of Complex Diseases, the University of Arizona, Tucson, AZ, USA. Electronic address: donata@arizona.edu.
Stephen J GalliDepartments of Pathology and of Microbiology and Immunology, Stanford University, Stanford, CA, USA. Electronic address: sgalli@stanford.edu.
Funding
Recruitment, Data Collection & Sample Management CoreP01AI148104 · NIAID · UNIVERSITY OF ARIZONA · PI Fernando D Martinez · 2020 to 2026
$19.0MTracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2013 to 2025
$17.3MTollip inhibits IL-33 signaling during airway influenza virus infectionU19AI125357 · NIAID · UNIVERSITY OF ARIZONA · PI KRAFT, MONICA, VERCELLI, DONATA · 2016 to 2025
$14.7MCharacterization of innate and IgE-mediated mast cell functions in honeybee venom allergy using Collaborative Cross miceR01AI165373 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2021 to 2025
$2.6MProbing basophil function in microfluidic systems for allergic disease diagnosisR21EB030643 · NIBIB · STANFORD UNIVERSITY · PI TANG, SINDY KAM-YAN · 2021 to 2023
$605kRole of Gamma delta-17 T Cells in Asthma Protection by Amish Farm Exposure .R21AI144722 · NIAID · UNIVERSITY OF ARIZONA · PI VERCELLI, DONATA · 2019 to 2020
$443kCharacterization of degranulation regulators in human mast cellsR21AI163438 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2021 to 2022
$433kNIAID NIH HHS P01 AI148104NIAID NIH HHS R01 AI165373NIAID NIH HHS R21 AI144722NIAID NIH HHS R21 AI163438NIAID NIH HHS U19 AI104209NIAID NIH HHS U19 AI125357NIBIB NIH HHS R21 EB030643
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID38875768
PMCPMC11500650
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390